Detalhe da pesquisa
1.
Association Between Type 2 Diabetes and Changes in Myocardial Structure, Contractile Function, Energetics, and Blood Flow Before and After Aortic Valve Replacement in Patients With Severe Aortic Stenosis.
Circulation
; 148(15): 1138-1153, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746744
2.
Cardiac reverse remodeling in primary mitral regurgitation: mitral valve replacement vs. mitral valve repair.
J Cardiovasc Magn Reson
; 25(1): 43, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37496072
3.
Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case-control study.
J Cardiovasc Magn Reson
; 24(1): 50, 2022 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089591
4.
Acute Microstructural Changes after ST-Segment Elevation Myocardial Infarction Assessed with Diffusion Tensor Imaging.
Radiology
; 299(1): 86-96, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33560187
5.
Insight Into Myocardial Microstructure of Athletes and Hypertrophic Cardiomyopathy Patients Using Diffusion Tensor Imaging.
J Magn Reson Imaging
; 53(1): 73-82, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558016
6.
Myocardial inflammation and energetics by cardiac MRI: a review of emerging techniques.
BMC Med Imaging
; 21(1): 164, 2021 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34749671
7.
Quantifying Myocardial Blood Flow and Resistance Using 4D-Flow Cardiac Magnetic Resonance Imaging.
Cardiol Res Pract
; 2023: 3875924, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36776959
8.
Sex- and age-specific normal values for automated quantitative pixel-wise myocardial perfusion cardiovascular magnetic resonance.
Eur Heart J Cardiovasc Imaging
; 24(4): 426-434, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458882
9.
A case report of refractory angina in a patient with diabetes and apical hypertrophic cardiomyopathy.
Eur Heart J Case Rep
; 6(8): ytac347, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045647
10.
Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes.
Obesity (Silver Spring)
; 30(5): 1079-1090, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35357083
11.
Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy.
Diabetes Care
; 45(8): 1852-1862, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789379
12.
Cardiovascular magnetic resonance phenotyping of heart failure with mildly reduced ejection fraction.
Eur Heart J Cardiovasc Imaging
; 24(1): 38-45, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36285884
13.
Prospective Longitudinal Characterization of the Relationship between Diabetes and Cardiac Structural and Functional Changes.
Cardiol Res Pract
; 2022: 6401180, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35178251
14.
Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.
Eur Heart J Cardiovasc Imaging
; 23(3): 352-362, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694365
15.
Validation of time-resolved, automated peak trans-mitral velocity tracking: Two center four-dimensional flow cardiovascular magnetic resonance study.
Int J Cardiol
; 364: 148-156, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716937
16.
Maternal Cardiac Changes in Women With Obesity and Gestational Diabetes Mellitus.
Diabetes Care
; 45(12): 3007-3015, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099225
17.
Cardiovascular magnetic resonance imaging: emerging techniques and applications.
Heart
; 107(9): 697-704, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33402364
18.
Rationale and design of the randomised controlled cross-over trial: Cardiovascular effects of empaglifozin in diabetes mellitus.
Diab Vasc Dis Res
; 18(3): 14791641211021585, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182806
19.
A 30-Year-Old Man With Primary Cardiac Angiosarcoma.
JACC Case Rep
; 3(6): 944-949, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34317662
20.
Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes.
Diabetes
; 70(12): 2810-2822, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610982